Ferritin Quantitative Test

Ferritin Rapid Quantitative Test (Chemiluminescence Immunoassay)

Ferritin Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Ferritin concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of malignant tumor or inflammation.

Product Detail

Application

Ferritin is a soluble tissue protein that stores iron in the human body. It is the most iron-rich protein complex, with a molecular weight of about 450,000 and containing 17% to 23% iron. Ferritin exists in various tissues and cells, especially in the liver, spleen, bone marrow, brain, and peripheral blood cells, including red blood cells, white blood cells, and platelets. Normal human serum contains a small amount of ferritin.

 

Ferritin plays an important dual role in the human body. It serves as a "reservoir" of iron for hemoglobin synthesis, and it also acts as a hollowed-in spherical protein that protects cells from excessive amounts of free iron, which can cause harmful effects.

 

Certain conditions can lead to increased ferritin levels in the body:

1. Acute infections and inflammatory diseases can promote the production of ferritin, the natural iron storage protein.

2. Hyperthyroidism can also cause ferritin to rise.

3. The increase of ferritin in malignant tumors is due to tumor invasion and necrosis, as well as the reduced ability of the liver to clear ferritin, and the increased synthesis of ferritin in tumor cells.

 

Specific types of cancer that can increase ferritin levels include:

Acute non-lymphocytic leukemia

Lymphoma

Liver cancer

Pancreatic cancer

Lung cancer

 

However, esophageal cancer, stomach cancer, colon cancer, and urinary system malignancies do not significantly affect ferritin levels.

 

Serum ferritin measurement can be used as a therapeutic indicator. Serum ferritin levels decrease in patients with effective treatment, but increase in patients with deterioration and recurrence. Continued increase in ferritin levels is associated with a poor prognosis. Therefore, serum ferritin measurement can be particularly useful for patients with alpha-fetoprotein-negative conditions.

 

Product Specification

Sample Volume

WB: 20μL; Serum/Plasma: 10μL

Test Time

10 mins

Measuring Range

0.50-1000 ng/mL

Pack

20T40T100T

Storage

2~30

 

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

 

Clinical significance

Iron Deficiency Anemia Diagnosis

Monitoring Iron Status

Evaluation of Fatigue and Weakness

Assessment of Hemochromatosis

Guiding Iron Supplementation

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay)
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay)
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the 25-hydroxyvitamin D (25 (OH) D) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of health check.
TSH/TT3/TT4 Rapid Quantitative Test (Fluorescence Immunoassay)
TSH/TT3/TT4 Rapid Quantitative Test (Fluorescence Immunoassay)
The Biotime TSH/TT3/TT4Rapid Quantitative Testis intended to quantitatively detect theconcentration of thyroid stimulating hormone (TSH),total triiodothyronine (TT3) and total thyroxine (TT4) in human serum and plasma samples on Biotime FIA Analyzer byfluorescent immunoassay. The test is used as an aiddiagnosis of thyroiddisease. For in vitro diagnostic use only. For professional use only.
biotime PGI PGII Rapid Quantitative Test
PGI/PGII Rapid Quantitative Test
Human pepsinogens I (PGI) and II (PGII) are proenzymes of pepsin—an endoproteinase of gastric juice. PGI is secreted mainly by chief cells in the fundic mucosa, whereas PGII is also secreted by the pyloric glands and the proximal duodenal mucosa. Serum PGI and PGII concentrations and the ratio between PGI and PGII may be related to the histologic and functional status of the gastric mucosa.
Cys C Rapid Quantitative Test
Cys-C Rapid Quantitative Test
Serum Cystatin C(Cys-C) has been proposed as a marker of glomerular filtration rate(GFR). Serum creatinine (creatinine) is widely used to estimate the glomerular filtration rate, but its tubular secretion, dependence on muscle mass, alteration in some inflammatory diseases, and analytical interferences can limit its utility. Thus, Cys-C has been proposed as a novel biomarker of kidney function.
Malaria Pf/Pv Antigen Qualitative Rapid Test
Malaria Pf/Pv Antigen Rapid Test
The Malaria P.f/P.v Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium vivax (P.v) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.
β-HCG Rapid Quantitative Test
β-HCG Rapid Quantitative Test
β-HCG is a fluorescent immunoassay for the quantitative measurement of β-HCG level in human serum and whole blood. This test is performed to help diagnose pregnancy if a woman is to undergo a medical treatment, be placed on certain drugs, or have other testing, such as x-rays, that might harm the developing baby.
Biotime PCT Rapid Quantitative Test
PCT Rapid Quantitative Test
PCT(Procalcitonin) is a peptide precursor of the hormone calcitonin. Measurement of PCT can be used as an authoritative marker for diagnosis and stratification of sepsis.
CMV IgG/IgM Rapid Test (Fluorescence Immunoassay)
CMV IgG/IgM Rapid Test (Fluorescence Immunoassay)
TheCMV IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toCMV in human serum. IgG results with this assay are used to indicate past or recent infection with CMV. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recent CMV infections. CMV IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Cytomegalovirus (CMV) infection -For in vitro diagnostic use only. For professional use only.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact